5,413 Shares in iRhythm Technologies, Inc. (NASDAQ:IRTC) Bought by Nomura Holdings Inc.

Nomura Holdings Inc. acquired a new position in iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 5,413 shares of the company's stock, valued at approximately $488,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in IRTC. Barclays PLC lifted its stake in shares of iRhythm Technologies by 34.3% in the third quarter. Barclays PLC now owns 209,247 shares of the company's stock worth $15,534,000 after acquiring an additional 53,498 shares during the period. Nisa Investment Advisors LLC lifted its stake in iRhythm Technologies by 166.6% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,037 shares of the company's stock valued at $94,000 after buying an additional 648 shares during the period. KBC Group NV lifted its stake in iRhythm Technologies by 45.1% in the fourth quarter. KBC Group NV now owns 1,319 shares of the company's stock valued at $119,000 after buying an additional 410 shares during the period. R Squared Ltd acquired a new position in iRhythm Technologies in the fourth quarter valued at approximately $45,000. Finally, Stephens Investment Management Group LLC lifted its stake in iRhythm Technologies by 25.6% in the fourth quarter. Stephens Investment Management Group LLC now owns 502,925 shares of the company's stock valued at $45,349,000 after buying an additional 102,600 shares during the period.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. The Goldman Sachs Group boosted their price target on iRhythm Technologies from $91.00 to $124.00 and gave the company a "neutral" rating in a research note on Monday, February 24th. Needham & Company LLC boosted their price target on iRhythm Technologies from $138.00 to $151.00 and gave the company a "buy" rating in a research note on Friday, May 2nd. Wells Fargo & Company raised iRhythm Technologies from an "equal weight" rating to an "overweight" rating and boosted their price target for the company from $104.00 to $130.00 in a research note on Friday, May 2nd. Wall Street Zen lowered iRhythm Technologies from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Finally, Robert W. Baird boosted their price target on iRhythm Technologies from $133.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $133.73.

iRhythm Technologies Stock Up 2.6%

Shares of NASDAQ:IRTC traded up $3.68 during trading on Tuesday, reaching $146.37. 263,470 shares of the stock were exchanged, compared to its average volume of 475,850. The company has a debt-to-equity ratio of 9.00, a current ratio of 6.27 and a quick ratio of 6.12. iRhythm Technologies, Inc. has a 1-year low of $55.92 and a 1-year high of $146.58. The stock has a fifty day moving average of $116.34 and a two-hundred day moving average of $104.16. The firm has a market cap of $4.67 billion, a price-to-earnings ratio of -40.21 and a beta of 1.34.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported ($0.95) earnings per share for the quarter, missing analysts' consensus estimates of ($0.89) by ($0.06). iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. The firm had revenue of $158.68 million for the quarter, compared to analyst estimates of $153.39 million. During the same period in the previous year, the company earned ($1.23) earnings per share. iRhythm Technologies's revenue for the quarter was up 20.3% compared to the same quarter last year. Research analysts anticipate that iRhythm Technologies, Inc. will post -1.98 earnings per share for the current fiscal year.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.